Core Viewpoint - Haida Group (002311) has announced a three-year dividend return plan for 2025-2027, committing to a cash dividend ratio of no less than 30% [1] Group 1: Dividend Policy - The annual profit distribution plan will balance sustainable development, long-term maximization of shareholder value, and reasonable returns for investors [1] - The company will prioritize cash dividends as the method of profit distribution [1] - Each year, the profit distribution plan will be determined based on the current operational situation and project investment funding needs [1]

Core Viewpoint - The announcement details the verification and public disclosure of the reserved grant portion of the 2024 stock option incentive plan for Shandong Bangji Technology Co., Ltd, confirming that all listed incentive objects meet the necessary legal and regulatory qualifications [1][2][3] Disclosure Situation - The company publicly announced the list of incentive objects and provided a 10-day period for employees to raise any objections regarding the proposed incentive recipients [1] - No objections were received from employees by the end of the public disclosure period [2] Supervisory Board Verification Opinion - The supervisory board conducted a verification of the incentive object list according to relevant regulations and confirmed that all individuals listed meet the qualifications set forth by the Company Law and other applicable regulations [2] - The verification process ensured that none of the listed individuals had been deemed inappropriate candidates by the securities exchange or the China Securities Regulatory Commission within the last 12 months, nor had they faced any significant legal penalties [2][3] - The supervisory board concluded that all individuals on the incentive object list are legally and effectively qualified to participate in the stock option incentive plan [3]

Meeting Overview - The shareholder meeting was held on May 21, 2025, with voting conducted through both on-site and online platforms [1] - A total of 288,554,215 shares were represented, accounting for 20.1356% of the company's total shares [1] Voting Results - Proposal 4 received 278,596,336 votes in favor, representing 99.8915% of the valid votes [2] - Proposal 5 received 278,575,636 votes in favor, representing 99.8999% of the valid votes [2] - Proposal 6 received 278,676,336 votes in favor, representing 99.8934% of the valid votes [2] - Proposal 7 received 278,545,936 votes in favor, representing 99.9601% of the valid votes [2] Minority Shareholder Voting - Among minority shareholders, 19,348,288 shares voted in favor of the proposals, accounting for 65.9079% of the valid votes [3] - The company announced that there would be no cash dividends, stock bonuses, or capital increases from reserves for the 2024 fiscal year [3] Related Shareholder Abstentions - Related shareholder Hunan Tangrenshen Holdings Co., Ltd. abstained from voting on certain proposals [4][5][6] - The voting results for various proposals showed a consistent trend of majority support from minority shareholders, with percentages around 64.67% to 66.39% in favor [5][15] Legal Compliance - The meeting was attended by lawyers from Hunan Yixing Law Firm, who confirmed that the meeting complied with relevant laws and regulations [16][17]

Core Viewpoint - Fujian Aonong Biotechnology Group Co., Ltd. is at risk of being delisted due to continuous losses from 2021 to 2023 and an audit report with an emphasis on the company's ability to continue as a going concern [1][3][4] Group 1: Reasons for Potential Delisting - The company has been under delisting risk warning since May 6, 2024, due to consecutive losses over the past three years and an audit report indicating concerns about its ongoing viability [1][3] - If the audited net assets attributable to shareholders are positive and the audit report for 2024 is unqualified, the company may apply to revoke the delisting risk warning [3][6] Group 2: Risk Warning Announcements - This announcement marks the fifth risk warning regarding potential delisting, following previous announcements made on February 14, February 28, March 14, and March 30, 2025 [2][5] - The company is required to disclose risk warning announcements every 10 trading days until the annual report is released, as per the Shanghai Stock Exchange regulations [2][5] Group 3: Other Matters - As of the date of the announcement, the audit work for the 2024 annual report is ongoing, and final financial data will be based on the officially disclosed audited report [5][6] - The company commits to fulfilling its information disclosure obligations in accordance with the relevant regulations [6]